KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.90 $2.79 Thursday, 25th Apr 2024 FGEN stock ended at $1.02. This is 3.63% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 13.75% from a day low at $0.90 to a day high of $1.03.
90 days $0.88 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Jun 08, 2021 $22.96 $24.47 $22.17 $24.25 1 463 645
Jun 07, 2021 $21.39 $23.15 $21.20 $22.90 1 407 429
Jun 04, 2021 $21.19 $21.42 $20.65 $21.15 390 718
Jun 03, 2021 $21.68 $21.73 $21.05 $21.08 553 488
Jun 02, 2021 $22.01 $22.24 $21.36 $21.65 1 218 218
Jun 01, 2021 $21.50 $22.23 $21.24 $21.83 824 430
May 28, 2021 $21.50 $21.95 $21.08 $21.25 568 455
May 27, 2021 $20.93 $21.92 $20.66 $21.25 614 597
May 26, 2021 $20.99 $21.02 $20.27 $20.86 521 222
May 25, 2021 $21.00 $21.17 $20.67 $20.67 531 428
May 24, 2021 $21.27 $21.39 $20.73 $20.76 385 166
May 21, 2021 $21.42 $21.47 $21.01 $21.19 460 071
May 20, 2021 $20.60 $21.39 $20.43 $21.31 529 375
May 19, 2021 $20.40 $20.79 $20.26 $20.55 410 151
May 18, 2021 $20.30 $21.35 $20.30 $20.75 797 236
May 17, 2021 $21.07 $21.65 $20.24 $20.27 884 312
May 14, 2021 $21.17 $21.74 $20.75 $21.56 661 629
May 13, 2021 $21.01 $21.65 $20.47 $21.04 855 496
May 12, 2021 $20.34 $21.79 $20.01 $21.13 1 236 443
May 11, 2021 $18.94 $21.30 $18.89 $20.15 1 591 236
May 10, 2021 $20.09 $20.17 $19.26 $19.42 1 077 157
May 07, 2021 $20.80 $21.22 $20.10 $20.23 683 434
May 06, 2021 $20.72 $20.95 $19.86 $20.64 727 893
May 05, 2021 $20.52 $21.32 $20.49 $20.93 695 355
May 04, 2021 $22.09 $22.15 $20.38 $20.54 839 956
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT